T1	Participants 79 121	HIV-associated B-cell non-Hodgkin lymphoma
T2	Participants 198 261	immunocompetent patients with B-cell non-Hodgkin lymphoma (NHL)
T3	Participants 347 365	HIV-associated NHL
T4	Participants 713 731	HIV-associated NHL
T5	Participants 1479 1502	HIV-associated lymphoma
